A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2004
11/11/2004	US20040223982 Neospora vaccine
11/11/2004	US20040223981 administering the live rotavirus immunogenic composition to an infant within seven to ten days of life followed by at least one additional administration of the composition prior to six months of age; does not cause transient low level fever or intussusception,
11/11/2004	US20040223980 Cold-adapted equine influenza viruses
11/11/2004	US20040223979 Chimeric flavivirus vaccines
11/11/2004	US20040223977 fusion peptide of an HIV CTL epitope and a T helper epitope induces potent epitope-specific CTL responses following a single administration in aqueous solution and can be further boosted with repeated administrations
11/11/2004	US20040223976 Influenza virus vaccine
11/11/2004	US20040223974 Vaccines, immunotherapeutics and methods for using the same
11/11/2004	US20040223973 antibodies obtained from a human after administration of a conjugate molecule comprising the S. typhi Vi polysaccharide covalently bound through a carboxylic acid dihydrazide linker to Pseudomonas aeruginosa recombinant exoprotein A.
11/11/2004	US20040223969 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA
11/11/2004	US20040223965 Hepatitis b core antigen fusion proteins
11/11/2004	US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004	US20040223949 administering a tumor antigen, fragment thereof or nucleic acid encoding it to produce an immune response and subsequently administering a high dose of a cytokine; provides an enhanced T cell response
11/11/2004	US20040223911 Stabilized therapeutic and imaging agents
11/11/2004	CA2558873A1 Treatment of iga1 deposition diseases
11/11/2004	CA2524124A1 Methods for treating cancer using an immunotoxin
11/11/2004	CA2524071A1 Toll-like receptor 9 effector agents and uses thereof
11/11/2004	CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	CA2523875A1 Sars virus nucleotide and amino acid sequences and uses thereof
11/11/2004	CA2523600A1 Methods utilising g-protein coupled receptor 54
11/11/2004	CA2523577A1 Methods for treating interleukin-6 related diseases
11/11/2004	CA2523402A1 Group 1 mite polypeptide variants
11/11/2004	CA2523319A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004	CA2523266A1 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004	CA2523025A1 Spex compositions and methods of use
11/11/2004	CA2521162A1 Single chain antigen-binding polypeptides for polymer conjugation
11/11/2004	CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2004	EP1475442A2 Polypeptides of feline T-cell lymphotropic lentivirus
11/10/2004	EP1475441A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/10/2004	EP1475440A2 Growth differentiation factor-3
11/10/2004	EP1475101A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1475100A1 Antibody-containing solution pharmaceuticals
11/10/2004	EP1474687A2 Marks as modifiers of the p53 pathway and methods of use
11/10/2004	EP1474535A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
11/10/2004	EP1474519A2 Microorganism for genetic therapeutic treatment of proliferative diseases
11/10/2004	EP1474510A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/10/2004	EP1474505A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof
11/10/2004	EP1474451A2 De-immunized (poly)peptide constructs
11/10/2004	EP1474449A2 Human antibodies for use as a therapeutic agent against vaccinia or small pox
11/10/2004	EP1474448A1 Rrp sequences and knockout mice and uses thereof
11/10/2004	EP1474447A2 Antigens for immunocontraception
11/10/2004	EP1474446A2 Mhc class ii peptide epitope of 5t4 antigen
11/10/2004	EP1474442A2 Cytotoxic t-cell epitopes from chlamydia
11/10/2004	EP1474432A1 Immunostimulatory, covalently lipidated oligonucleotides
11/10/2004	EP1474169A2 Means and methods for altering the motility of the gastrointestinal tract
11/10/2004	EP1474168A1 7s immunoglobulin for treatment of choroidal neovascularisation
11/10/2004	EP1474167A2 Novel proteins in enteroaggregative esheriachia coli (eaec) useful for diagnosis and therapy of eaec infections
11/10/2004	EP1474166A2 Ehrlichia disulfide bond formation proteins and uses thereof
11/10/2004	EP1474153A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
11/10/2004	EP1474149A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
11/10/2004	EP1474120A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/10/2004	EP1474067A2 One dose vaccination with i mycoplasma hyopneumoniae /i
11/10/2004	EP1045700B1 Oral delivery of nucleic acid vaccines by particulate complexes
11/10/2004	EP0998301B1 Nucleic acid based immunotherapy of chronic hepatitis b infection
11/10/2004	CN1545552A Genes and proteins, and their uses
11/10/2004	CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein
11/10/2004	CN1545417A Novel vaccine for prophylaxis and theraphy in vetirinary and human medicine
11/10/2004	CN1544638A Virus-like particle capable of carrying and loading polypeptide
11/10/2004	CN1544630A Method for preparing recombinant duck interleukin-2 protein and its application
11/10/2004	CN1544629A Method for preparing recombinant goose interleukin-2 protein and its application
11/10/2004	CN1544628A Trichina TS88 gene, their protein products and uses
11/10/2004	CN1544473A Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses
11/10/2004	CN1544471A Bovine mastitis resistant yolk antibody and its preparation method and formulation
11/10/2004	CN1544460A Protein A immunoadsorption medium regeneration and utilization process
11/10/2004	CN1544090A Pig immunoglobulin contained oral medicine
11/10/2004	CN1544089A DNA vaccine for preventing influenza virus infection
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/10/2004	CN1174997C Terminal blocked pentahelicoprotein and its use
11/10/2004	CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/09/2004	US6815540 Improved solubility/yield/ease of handling; fusion proteins; for diagnostics/drugs/research
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815201 HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies
11/09/2004	US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004	US6815160 By screening blood; kits; comprises anti-human/mono/polyclonal antibody-virus complexes; solid phase synthesis
11/09/2004	US6814981 Ganglioside immunostimulating complexes and uses thereof
11/09/2004	US6814971 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a bordetella infections and/or a toxigenic pasteuralla infections
11/09/2004	US6814970 Present on the surface of borrelia burgdorferi cells that lack the outer membrane proteins ospa, ospb, ospc and ospd; sensitive to cleavage with proteinase k; having binding affinity for certain monoclonal antibodies
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	US6814968 Inhibition of viral infection and spread with viral and RhoA-derived peptides
11/09/2004	US6814967 Polypeptides
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814953 Bronchodilating compositions and methods
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/09/2004	CA2109572C Method for reducing side-effects of a drug
11/09/2004	CA2078985C Influenza virus vaccine composition having a synergic effect and containing influenza virus core as an additive
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004094988A2 Tolerance to graft prior to thymic regeneration
11/04/2004	WO2004094649A2 Tolerance to graft following thymic reactivation
11/04/2004	WO2004094644A2 Vibrio cholerae proteins expressed during infection
11/04/2004	WO2004094639A2 Recombinant fel d 1 allergen
11/04/2004	WO2004094637A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	WO2004094620A2 Truncated baff receptors
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094607A2 Methods of therapy and diagnosis using targeting of cells that express a human transporter-like protein
11/04/2004	WO2004094600A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004094596A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/04/2004	WO2004094473A2 Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
11/04/2004	WO2004094469A1 Tuberculosis vaccine with improved efficacy
11/04/2004	WO2004094467A2 H. pylori antigens

1 ... 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 ... 1823